Use of Text Messaging Reminders to Increase FIT Completion Among Patients at the NYU FHCs

December 18, 2025 updated by: NYU Langone Health

Use of Text Messaging Reminders to Increase FIT Completion Among Patients at the New York University (NYU) Family Health Centers (FHCs)

The research team will compare the efficacy of targeted text message reminders against currently used phone call reminders at increasing patient completion of fecal immunochemical test (FIT) for colon cancer screening.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

1283

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • New York
      • New York, New York, United States, 10016
        • NYU Langone Health

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Study Population

Adult patients (ages 45-75) eligible for FIT at a Family Health Center clinic (excluding Flatbush locations).

Description

Inclusion Criteria:

  • Adult patients eligible for FIT at a Family Health Center clinic (excluding Flatbush locations).

Exclusion Criteria:

  • See inclusion criteria.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Text Message Reminders
Participants will receive text message reminders to complete FIT for colon cancer screening.
Behavioral: Text Message Reminders
Text message reminders (instead of usual care - phone call reminders) to complete FIT for colon cancer screening.
No Intervention: Usual Care (Phone Call Reminders)
Participants will receive usual care (phone call reminders to complete FIT for colon cancer screening).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
FIT Completion at 7 Days Post-FIT Test Order
Time Frame: Day 7 Post-Visit
Day 7 Post-Visit
FIT Completion at 14 Days Post-FIT Test Order
Time Frame: Day 14 Post-Visit
Day 14 Post-Visit
FIT Completion at 21 Days Post-FIT Test Order
Time Frame: Day 21 Post-Visit
Day 21 Post-Visit

Secondary Outcome Measures

Outcome Measure
Time Frame
Total Time to Completion of FIT Test
Time Frame: Up to Day 21 Post-Visit
Up to Day 21 Post-Visit

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

NYU Langone Health

Investigators

  • Principal Investigator: Leora Horwitz, MD, MHS, NYU Langone Health

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 7, 2025

Primary Completion (Actual)

June 24, 2025

Study Completion (Actual)

July 15, 2025

Study Registration Dates

First Submitted

October 7, 2024

First Submitted That Met QC Criteria

October 7, 2024

First Posted (Actual)

October 8, 2024

Study Record Updates

Last Update Posted (Actual)

December 19, 2025

Last Update Submitted That Met QC Criteria

December 18, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • QI- Fit Testing Trial

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

This is a quality improvement (QI) project and individual participant data (IPD) will not be shared with other researchers.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe